MAP4K3 and non-small cell lung carcinoma: The association between the recurrence risks and GLK protein levels was higher than that between the recurrence risks and the pathologic stages (OR = 3.67, 95% CI, 0.82–16.4, P = 0.089; Table 2) in NSCLC patients with a surgery resection.